Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients

Authors

  • Guilherme Suarez-Kurtz Instituto Nacional de Câncer https://orcid.org/0000-0002-1115-8319
  • Cristina Wiggers Almeida Hospital Federal da Lagoa
  • Eduardo Chapchap Hospital Albert Einstein
  • Márcia Trindade Schramm Instituto Nacional de Câncer
  • Maura Rosane Valério Ikoma-Coltutato Fundação Amaral Carvalho
  • Mecneide Mendes Lins Instituto de Medicina Integral Professor Fernando Figueira
  • Teresa Cristina Cardoso Fonseca Santa Casa de Misericórdia de Itabuna
  • Thais Ferraz Aguiar Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti
  • Mariana Emerenciano Instituto Nacional de Câncer https://orcid.org/0000-0003-2337-8420

DOI:

https://doi.org/10.1016/j.clinsp.2023.100214

Downloads

Download data is not yet available.

Downloads

Published

2023-05-06

Issue

Vol. 78 (2023)

Section

Comments

How to Cite

Suarez-Kurtz, G., Almeida, C. W., Chapchap, E., Schramm, M. T., Ikoma-Coltutato, M. R. V., Lins, M. M., Fonseca, T. C. C., Aguiar, T. F., & Emerenciano, M. (2023). Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients. Clinics, 78, 100214. https://doi.org/10.1016/j.clinsp.2023.100214